Zacks Research Has Pessimistic Outlook of CLB Q3 Earnings

Core Laboratories Inc. (NYSE:CLB) – Zacks Research reduced their Q3 2025 earnings estimates for shares of Core Laboratories in a research report issued to clients and investors on Friday, January 17th. Zacks Research analyst T. Saha now expects that the oil and gas company will post earnings of $0.27 per share for the quarter, down from their previous forecast of $0.28. The consensus estimate for Core Laboratories’ current full-year earnings is $0.80 per share. Zacks Research also issued estimates for Core Laboratories’ Q1 2026 earnings at $0.24 EPS and Q3 2026 earnings at $0.32 EPS.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.21 by $0.04. The company had revenue of $134.40 million for the quarter, compared to analyst estimates of $134.16 million. Core Laboratories had a net margin of 5.83% and a return on equity of 15.84%. Core Laboratories’s revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.22 EPS.

A number of other research firms also recently issued reports on CLB. Citigroup reduced their price target on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research note on Thursday, October 31st. StockNews.com raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $17.00.

Core Laboratories Price Performance

Core Laboratories stock opened at $19.73 on Monday. The company’s 50 day simple moving average is $19.10 and its 200-day simple moving average is $19.56. The company has a market capitalization of $926.51 million, a price-to-earnings ratio of 30.36, a price-to-earnings-growth ratio of 0.98 and a beta of 2.39. Core Laboratories has a 1 year low of $13.82 and a 1 year high of $25.13. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.79 and a current ratio of 2.48.

Institutional Investors Weigh In On Core Laboratories

Hedge funds and other institutional investors have recently modified their holdings of the company. State Street Corp raised its holdings in shares of Core Laboratories by 2.9% in the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock valued at $36,597,000 after purchasing an additional 56,187 shares in the last quarter. Disciplined Growth Investors Inc. MN raised its stake in Core Laboratories by 446.8% during the 2nd quarter. Disciplined Growth Investors Inc. MN now owns 4,460,720 shares of the oil and gas company’s stock worth $90,508,000 after acquiring an additional 3,644,963 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in Core Laboratories by 12.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 306,287 shares of the oil and gas company’s stock worth $6,215,000 after acquiring an additional 34,149 shares in the last quarter. Geode Capital Management LLC raised its stake in Core Laboratories by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock worth $19,521,000 after acquiring an additional 7,721 shares in the last quarter. Finally, Earnest Partners LLC grew its position in Core Laboratories by 6.3% during the 2nd quarter. Earnest Partners LLC now owns 3,286,438 shares of the oil and gas company’s stock worth $66,682,000 after purchasing an additional 195,756 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Stockholders of record on Monday, November 4th were issued a $0.01 dividend. The ex-dividend date was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.20%. Core Laboratories’s payout ratio is 6.15%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.